Nadia Waheed's most recent trade in Ocular Therapeutix Inc was a trade of 3,510 Common Stock done at an average price of $7.7 . Disclosure was reported to the exchange on Feb. 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.74 per share. | 20 Feb 2026 | 3,510 | 314,907 (0%) | 0% | 7.7 | 27,167 | Common Stock |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.04 per share. | 12 Feb 2026 | 7,863 | 318,417 (0%) | 0% | 9.0 | 71,082 | Common Stock |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 240,932 | 240,932 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 79,112 | 326,280 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 122,923 | 122,923 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 40,363 | 247,168 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 02 Jun 2025 | 13,861 | 206,805 (0%) | 0% | 8.0 | 111,581 | Common Stock |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 237,000 | 237,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 79,000 | 220,666 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 425,000 | 425,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 141,666 | 141,666 (0%) | 0% | 0 | Common Stock |